MarketBeat vs Portfolio123
A detailed comparison to help you choose the right tool in 2026.
MarketBeat
Stock market news and research tools for smarter investing
Free plan available
Portfolio123
Quantitative stock screening and portfolio backtesting for systematic investors
Free plan available
Feature Comparison
| Feature | MarketBeat | Portfolio123 |
|---|---|---|
| Fundamental screening | ✓ | ✓ |
| Technical screening | ✓ | ✓ |
| Real-time scanning | ✗ | ✗ |
| Custom filters | ✓ | ✓ |
| Visual screener/heat maps | ✗ | ✗ |
| Data export | ✓ | ✓ |
| Alerts | ✓ | ✗ |
| Pre-built screens | ✓ | ✓ |
| Starting Price | Free | Free |
MarketBeat Pros & Cons
Pros
- + Generous free tier with more analyst data than many paid competitors
- + Excellent aggregation of ratings, insider trades, earnings, dividends
- + Powerful screeners with 100+ filters and a strong dividend screener
- + Highly customizable email and SMS alerts
- + Clean, well-designed newsletter praised for ease of use
- + Twice-daily premium newsletters save significant research time
Cons
- − Aggressive email and SMS marketing — users report being flooded
- − Difficult to unsubscribe — common complaint about continued emails
- − Most data is publicly available elsewhere for free
- − Best screeners locked behind $399/yr All Access paywall
- − No proprietary stock analysis — aggregates rather than creates research
Portfolio123 Pros & Cons
Pros
- + Institutional-grade FactSet data with point-in-time accuracy
- + Deepest fundamental backtesting engine available to retail investors
- + 64 pre-built ranking systems spanning value, growth, quality, and momentum
- + No programming required for quantitative strategies
- + Commission-free live execution via Tradier and Interactive Brokers
Cons
- − Steep learning curve for factor modeling and ranking systems
- − No mobile app — web-only platform
- − Interface is functional but dated compared to modern fintech tools
- − No integrated news feed or social features
- − Charting and technical analysis tools are limited
Our Take
MarketBeat: MarketBeat excels at consolidating analyst ratings, insider trades, earnings data, and dividend information into one well-organized feed. The twice-daily newsletters save research time for investors who value curated market updates. The free tier is worth trying for analyst data alone, and the All Access screener suite adds genuine value for income and value investors. Aggressive marketing practices remain the platform's most significant drawback — weigh that against the data quality before committing.
Portfolio123: Portfolio123 is the most powerful quantitative screening and backtesting platform available to retail investors. Its combination of institutional-grade FactSet data, 20-year point-in-time backtesting, multi-factor ranking systems, and commission-free broker integration creates genuine analytical depth that no consumer alternative matches. The learning curve is steep and the interface is dated, but for systematic investors willing to invest the time, no other platform delivers this level of quantitative rigor at $25-83/month.
Pricing Comparison
MarketBeat Pricing
MarketBeat structures its pricing across three tiers. The free tier provides basic analyst ratings, a daily newsletter, and a five-stock portfolio — enough to evaluate the platform but not to use it seriously. Daily Premium at nineteen ninety-seven per month (or one hundred ninety-nine dollars per year) unlocks unlimited watchlists, twice-daily newsletters, full alerts, and an ad-free experience. All Access at thirty-nine ninety-seven per month (or three hundred ninety-nine dollars per year) adds stock screeners, the Idea Engine, analyst ratings screener, and CSV export. A thirty-day money-back guarantee reduces commitment risk. Compared to Seeking Alpha Premium at two hundred ninety-nine dollars per year or TipRanks at roughly one hundred dollars, MarketBeat's All Access tier is priced at a premium — justified only if you value the newsletter delivery, insider tracking, and screener suite as an integrated package rather than seeking best-in-class in any single category.
Portfolio123 Pricing
Portfolio123's pricing is straightforward and competitive for the depth of tooling it provides. The free tier includes broker integration with Tradier and Interactive Brokers, fundamental charting, and a consolidated brokerage account view — useful but limited for research. The Screener plan at $25/month unlocks the full financial database, 460-plus screening metrics, and five years of backtesting data. The Pro plan at $83/month adds 20 years of backtesting, multi-factor ranking systems, rolling screens, position sizing, and API access. Annual billing saves 28% on Retail plans and 23% on Pro plans. A 21-day trial at $19 provides full Pro-level access with 10 years of data and no auto-renewal — a low-risk way to evaluate the platform. For context, Stock Rover Premium Plus costs $28/month with shallower backtesting, while Trade Ideas starts at $118/month for a narrower use case.
What Users Say
MarketBeat
User sentiment toward MarketBeat splits along a clear line: the data is praised, but the marketing is criticized. On Trustpilot, the platform holds a 3.7 out of 5 rating across 686 reviews, with fifty-three percent awarding five stars. Long-term subscribers describe the newsletters as "timely," "informative and balanced," and valuable for staying current on analyst activity and earnings. The BBB rating stands at A+, and Traders Union rates the platform at 4.4 out of 5. However, sixteen percent of Trustpilot reviews are one-star, driven overwhelmingly by complaints about email and SMS marketing volume. Reviewers describe being "spammed" with promotional messages and struggling to unsubscribe. Others call the interface outdated and report periodic site stability issues. The pattern is consistent — investors who engage with MarketBeat's core research tools tend to stay subscribed for years; those who encounter the marketing machinery first often leave frustrated.
Portfolio123
User sentiment is overwhelmingly positive among those who invest the time to learn the platform. On Trustpilot (4.8/5, 50 reviews), 88% of ratings are five stars — an unusually high concentration. Users describe it as "the best quant platform for retail users" and "simply the best product for quantitative stock analysis." Several long-term members report that Portfolio123 "genuinely changed my life as an investor," citing the shift from intuition-based to systematic, data-driven decision-making. Professional reviewers at GreatWorkLife and LiberatedStockTrader both award 4.1/5, praising screening depth and backtesting power while noting the learning curve. The sole recurring negative theme is the steep onboarding — not the platform's capability or value. One Trustpilot reviewer gave a single star citing community dynamics, but this is an extreme outlier against 49 four- and five-star ratings.
Choose MarketBeat if...
- → Self-directed investors who want a single dashboard for analyst ratings, earnings, insider trades, and dividend data
- → MarketBeat is ideal for self-directed investors who want a single dashboard for analyst ratings, insider trades, earnings calendars, and dividend data. If you check analyst consensus before making buy or sell decisions, the platform aggregates that data more efficiently than hunting across multiple free sources. Income investors benefit from the dividend screener and payout tracking. Swing traders who monitor institutional flows and insider buying patterns will find the alert system — delivering real-time notifications via email and SMS — saves significant research time. Newsletter-focused investors who prefer curated market updates over raw data feeds will appreciate the twice-daily premium editions. If you already use a brokerage with built-in research, MarketBeat serves as a strong second-opinion layer.
Choose Portfolio123 if...
- → Systematic investors who want quantitative factor-based portfolio construction without coding
- → Portfolio123 is built for self-directed investors who want to take a systematic, data-driven approach to stock selection. If you are interested in building multi-factor ranking systems, screening across hundreds of fundamental and technical metrics, and backtesting strategies against decades of point-in-time data, this platform delivers at a level no consumer alternative matches. Dividend investors and growth-oriented stock pickers benefit especially from the factor library and pre-built screens. Portfolio managers, RIAs, and academic researchers will find institutional-grade FactSet data at a fraction of terminal costs. The platform suits anyone who wants the rigor of quantitative investing without the programming requirements of tools like QuantConnect.
Frequently Asked Questions
What is the main difference between MarketBeat and Portfolio123?
MarketBeat is best known for: Stock market news and research tools for smarter investing. Portfolio123 focuses on: Quantitative stock screening and portfolio backtesting for systematic investors.
Which is cheaper, MarketBeat or Portfolio123?
MarketBeat offers a free tier. Portfolio123 also offers a free tier.
Can I use MarketBeat and Portfolio123 together?
Yes, many traders use both tools as they serve complementary purposes. MarketBeat excels at analyst ratings database with 1.5m+ recommendations, while Portfolio123 is strong in 460+ fundamental, technical, and sentiment screening metrics.